Latest News
An update on the macular degeneration drug pipeline, the signs and symptoms of age-related macular degeneration (AMD), a new clinical trial that aims to reduce the frequency of wet AMD injections, the role of sleep apnea in AMD, and more are found in the spring 2019 edition of Macular Degeneration Research News.
BrightFocus Foundation announces a new national public service campaign to increase awareness and understanding of Alzheimer’s disease.
A recent study focused attention on whether Alzheimer’s disease can spread from one human to another. The risk remains small as long as standard precautions are followed during surgery and other procedures.
The winter 2019 edition of the National Glaucoma Research Report provides answers to the top five questions asked about glaucoma, describes a new method to inhibit inflammation and prevent glaucoma, lists several apps for people with low vision, outlines a clinical research study underway to save sight from glaucoma, and more.
Learn about a new approach for memory improvement in Alzheimer's disease, a study exploring selective memory in the Alzheimer’s disease brain, research disaster preparedness for Alzheimer’s caregivers, how to reduce the risk of vascular dementia with a brain-healthy lifestyle, and more in the 2019 winter edition of Alzheimer's Disease Research Review..
An oral supplement to treat advanced AMD, gene therapy for eye diseases, 5 clinical trial myth busters, summaries of 2 of the 18 new grants Macular Degeneration Research recently awarded to help fight AMD, and more are found in the fall 2018 edition of Macular Degeneration Research News.
BrightFocus Foundation, a Maryland-based nonprofit and a leading source of worldwide research funding on diseases of mind and sight, was recently awarded a Seal of Excellence from the Maryland Nonprofits Standards for Excellence Institute. This is the organization’s third time receiving this distinction.
The fall edition of the Alzheimer's Disease Research Review provides information on how improving brain blood flow could improve cognitive function in people who have Alzheimer's, the influence of genetics on Alzheimer's, a clinical trial examining the effects of physical activity on the dementia risk for older African Americans, and the uses and misuses of antipsychotic medications for managing challenging behaviors associated with Alzheimer's.